Reed Elizabeth E

Chief Legal Officer and GCTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Sell(S)2K$43.95$91K105K
May 5, 2026Sell(S)2K$46.65$101K107K
May 4, 2026Option exercise(M)4K$0109K
May 4, 2026Option exercise(M)20K$17.96$359K125K
May 4, 2026Sell(S)20K$45.00$900K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)20K$00
May 4, 2026Grant(A)9K$09K
May 4, 2026Option exercise(M)4K$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001283303-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly: